This bill aims to improve diabetes management in Florida by enhancing access to healthcare and medication. It requires the Department of Health to establish a website to help individuals find federally qualified health centers, which must make a good faith effort to schedule appointments within 30 days. Additionally, pharmacists are authorized to prescribe and dispense a 30-day supply of insulin and other diabetes-related medications under certain conditions, with a prohibition on charging patients more than their insurance copayment or the usual cost if uninsured. The Department of Health will also inform pharmacists about these new requirements.

Moreover, the bill introduces new sections to Florida Statutes that mandate health insurance policies and health maintenance contracts to cover laboratory and diagnostic testing for diabetes, while capping out-of-pocket expenses at $35 for a 30-day supply of insulin or glucagon drugs and $100 for diabetes devices. These provisions will apply to policies issued or renewed after January 1, 2026. The bill also redesignates existing subsections within the prescription drug monitoring program and adds requirements for reporting diabetes-related medications and devices, ensuring that dispensers report all relevant items to the monitoring system. The act is set to take effect on July 1, 2025.